Chemcrux Enterprises Ltd

Chemcrux Enterprises Ltd has announced the closure of its trading window for designated persons, their immediate relatives, and connected persons. This closure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code of conduct. The window will be shut from July 1, 2026, to facilitate the consideration of the unaudited financial results for the quarter ending June 30, 2026. Trading will resume 48 hours after the declaration of these results. The specific date for the board meeting to approve these results will be communicated later. This measure is intended to prevent potential insider trading.

Chemcrux Enterprises Ltd's wholly-owned subsidiary, Kalichem Private Limited, has filed an application for amendment to Consent to Establish (CTE) with the Gujarat Pollution Control Board (GPCB). This move is part of Kalichem's proposed diversification into the inorganic chemical sector at its manufacturing facility in Vadodara, Gujarat. The CTE amendment seeks approval for the addition of various inorganic chemicals to its production capabilities.

Chemcrux Enterprises Ltd's Board of Directors recommended a final dividend of 10% (Re. 1/- per share) on equity shares of Rs. 10/- each for the financial year 2025-26, subject to shareholder approval at the upcoming Annual General Meeting. The board also approved the incorporation of a wholly-owned, non-profit subsidiary under Section 8 of the Companies Act, 2013, to fulfill CSR obligations.

Chemcrux Enterprises Ltd's board approved the incorporation of a wholly-owned, non-profit subsidiary under Section 8 of the Companies Act, 2013. The subsidiary's name is pending approval from the Ministry of Corporate Affairs. The board also approved the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, and recommended a final dividend of 10% (Re. 1/- per share) for FY 2025-26, subject to shareholder approval.

Chemcrux Enterprises Ltd's board approved audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. The board recommended a final dividend of 10% (₹1 per share) on equity shares of ₹10 each for FY 2025-26, subject to shareholder approval. The meeting, held on May 14, 2026, also included the auditor's report with an unmodified opinion on the financial statements.

Chemcrux Enterprises Ltd's board meeting on May 14, 2026, approved the audited standalone and consolidated financial statements and results for the quarter and year ended March 31, 2026. The board also recommended a final dividend of 10% (₹1 per share) for FY 2025-26, subject to shareholder approval. Additionally, the board approved the incorporation of a wholly-owned, non-profit subsidiary under Section 8 of the Companies Act, 2013, to fulfill CSR obligations. The meeting commenced at 11:30 A.M. and concluded at 04:10 P.M.

Chemcrux Enterprises Ltd has scheduled a Board of Directors meeting on May 14, 2026, to consider and approve the audited financial statements and results for the quarter and year ended March 31, 2026. The board will also consider the recommendation of a final dividend for the fiscal year 2025-26, subject to shareholder approval. The trading window for dealing in the company's shares has been closed since April 1, 2026, and will reopen 48 hours after the financial results are made public.

Chemcrux Enterprises Ltd has announced a Board of Directors meeting scheduled for May 14, 2026, to consider and approve the audited financial statements and results for the quarter and year ended March 31, 2026. The board will also consider the recommendation of a final dividend for FY 2025-26, subject to shareholder approval. The trading window for dealing in the company's shares has been closed and will reopen 48 hours after the results are made public.

Chemcrux Enterprises Ltd responded to an email from BSE Limited dated April 17, 2026, seeking clarification on significant price movement in the company's securities. The company stated that it has regularly intimated BSE of all events and price-sensitive information as required by Regulation 30 of SEBI (LODR) Regulations, 2015. Chemcrux confirmed that it has not withheld any information that would impact its share price. The company attributed the share price movement purely to market conditions, asserting it has no control over or knowledge of the reasons behind such movements.

Chemcrux Enterprises Ltd. has announced the closure of its trading window for all designated persons, their immediate relatives, and connected persons. The closure is in compliance with the SEBI (Prohibition of Insider Trading) Regulations, 2015 and in accordance with the company's Code of Conduct to Regulate, Monitor and Report Trading by Designated Persons. The trading window will remain closed from 1st April 2026 for the purpose of consideration of Audited Financial Results for the quarter and year ending on 31st March 2026. The window will open 48 hours after the declaration of the audited financial results to the Stock Exchange. The date of the Board Meeting for the consideration of the audited financial results will be communicated in due course.